Financing ·
Glucotrack raises $2M via convertible notes and announces 1-for-2 reverse stock split effective Oct. 26
GCTKGlucotrack, Inc.
On October 22, 2026, Glucotrack entered into a private placement agreement to issue senior secured convertible promissory notes with an aggregate principal amount of $2,564,102 for gross proceeds of $2,000,000. The nine-month notes bear interest at 8% per annum and are convertible at a price equal to the lower of $0.6390 or 80% of the lowest daily volume-weighted average price over the preceding fifteen trading days. Concurrently, the company issued warrants to purchase 8,025,360 shares of common stock exercisable at $1.5975 per share for five years. Additionally, Glucotrack announced a 1-for-2 reverse stock split of its common stock, effective with the opening of trading on October 26, 2026, to help regain compliance with Nasdaq's minimum bid price requirement. The company operates Lōkahi Therapeutics, a biopharmaceutical platform focused on innovative therapeutic opportunities and continuous blood glucose monitoring technologies.